In the News: Yale Research Coming to Target

TummyZen

Eli Consumer Healthcare is producing its new zinc-based antacid for acid reflux, a problem that plagues a quarter of adult Americans. TummyZen – slated for sale nationally in Target stores next month – is based on the research of Yale University gastrointestinal surgeon John P. Geibel, who showed that zinc reduces acid secretion in the stomach.  

His research led to a patent and eventual product out of the Yale Office of Cooperative Research, which aims to pair promising faculty research with promising SOM students.

Full coverage from Marie McCullough at the Philadelphia Inquirer.

Comments are closed.